Modern disease-modifying drugs (DMTs) have revolutionized the treatment of relapsing-remitting multiple sclerosis (MS). However, their use during pregnancy has long been concerning.
A study published in The Lancet Regional Health – Europe provides valuable insights into the safety of these medications during pregnancy, based on data from the German MS and Pregnancy Registry.
This study confirms that beta-interferons and glatiramer acetate are safe for use during early pregnancy. In addition, fumarate is likely a safe treatment option during pregnancy, and natalizumab and CD20 antibodies are viable treatment options for women with highly active MS.
In an interview with Medscape Medical News, Wolfgang Paulus, MD, from the Reproductive Toxicology Advisory Center at the University Women’s Clinic in Ulm, Germany,…